Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity

Open access

Published version of a preprint

Abstract

The glucagon-like peptide 1 receptor (GLP1R) is a major drug target with several agonists being prescribed in individuals with type 2 diabetes and obesity 1,2. The impact of genetic variability of GLP1R on receptor function and its association with metabolic traits are unclear with conflicting reports. Here, we show an unexpected diversity of phenotypes ranging from defective cell surface expression to complete or pathway-specific gain of function (GoF) and loss of function (LoF), after performing a functional profiling of 60 GLP1R variants across four signalling pathways. The defective insulin secretion of GLP1R LoF variants is rescued by allosteric GLP1R ligands or high concentrations of exendin-4/semaglutide in INS-1 823/3 cells. Genetic association studies in 200,000 participants from the UK Biobank show that impaired GLP1R cell surface expression contributes to poor glucose control and increased adiposity with increased glycated haemoglobin A1c and body mass index. This study defines impaired GLP1R cell surface expression as a risk factor for traits associated with type 2 diabetes and obesity and provides potential treatment options for GLP1R LoF variant carriers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42255-023-00889-6

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 56

Metadata

Authors
Gao, W., Liu, L., Huh, E., Gbahou, F., Cecon, E., Oshima, M., Houzé, L., Katsonis, P., Hegron, A., Fan, Z., Hou, G., Charpentier, G., Boissel, M., Derhourhi, M., Marre, M., Balkau, B., Froguel, P., Scharfmann, R., Lichtarge, O., Dam, J., Bonnefond, A., Liu, J., & Jockers, R.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Baylor College of Medicine (US)
  • Huazhong University of Science and Technology (CN)
  • Centre d'Etudes et de Recherches pour l'Intensification du Traitement du Diabète (FR)
  • Inserm (FR)
  • Université Paris-Sud (FR)
Corresponding author
  • Liu, Jianfeng
  • Jockers, Ralf
Venue
Nature Metabolism
Published
2023-09-14
Volume
5
Issue
10
Pages
1673-1684
ISSN
2522-5812 (ISSN-L)
OpenAlex
W4386740781
Cited by
56
References
39
Citations by year
2026: 20 · 2025: 16 · 2024: 19 · 2023: 1
FWCI
11.42
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Metabolism (publishedVersion)
  • Research Square (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • HAL (submittedVersion, cc-by)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
Funders
  • European Commission (ANR-10-LABX-46)
  • Agence Nationale de la Recherche (ANR-18-IBHU-0001, ANR‐10‐LABX‐46, ANR‐2011‐BSV1‐012‐01, ANR-10-INBS-0009, ANR-11-LABX-0071, ANR‐10‐EQPX‐07‐01, 10-LABX-46, ANR18, IDEX-0005, ANR-2011-META, ANR-11-IDEX, ANR-21-CE18-0023, ANR-10, ANR-10-INBS-009, ANR-11-IDEX-0005, ANR-10-EQPX)
  • Institut National de la Santé et de la Recherche Médicale
  • National Natural Science Foundation of China (81720108031, 2021ZD0203302, 2018YFA0507003, 81872945, 31721002)
  • Centre National de la Recherche Scientifique
  • Conseil Régional Hauts-de-France
  • National Institutes of Health (-0001)
  • Medical Research Council (MC_PC_17228)
  • National Institute of General Medical Sciences (R01GM066099)
  • H2020 European Research Council (715575)
  • FP7 Ideas: European Research Council (294785)
  • CHIST-ERA
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
GLP-1 receptor, genetic variants, cell surface expression, loss of function, gain-of-function, insulin secretion, glucose homeostasis, adiposity, type 2 diabetes, obesity, cAMP signaling, exendin-4, semaglutide, allosteric ligands, glycated haemoglobin A1c, body mass index
MeSH terms
Blood Glucose, Diabetes Mellitus, Type 2, Humans, Insulin, Obesity, Adiposity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity. https://app.cochat.ai/papers/10.1038/s42255-023-00889-6
The paper
Gao, W., Liu, L., Huh, E., Gbahou, F., Cecon, E., Oshima, M., Houzé, L., Katsonis, P., Hegron, A., Fan, Z., Hou, G., Charpentier, G., Boissel, M., Derhourhi, M., Marre, M., Balkau, B., Froguel, P., Scharfmann, R., Lichtarge, O., . . . Jockers, R. (2023). Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity. Nature Metabolism. https://doi.org/10.1038/s42255-023-00889-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.